Berry Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Berry Group's ABBV Position: Q4 2020 in Review
Berry Group increased its AbbVie (ABBV) stake by 5.8% in Q4 2020, buying an estimated $60.5K and bringing the position to 11,566 shares worth $1.24M. The position accounts for 0.56% of the portfolio, ranked #39.
Berry Group first reported a position in ABBV in Q4 2019 and has held it in 5 quarters since. 2,597 funds tracked by Wall St. Rank hold ABBV as of Q4 2020.
- Berry Group held 11,566 shares of AbbVie worth $1.24M as of Q4 2020.
- Berry Group bought 630 AbbVie shares in Q4 2020, an estimated $60.5K.
- AbbVie made up 0.56% of Berry Group's portfolio in Q4 2020, its #39 holding.
- Berry Group first reported a position in AbbVie in Q4 2019 and has held it in 5 quarters since.
- 2,597 funds tracked by Wall St. Rank held AbbVie as of Q4 2020.
Based on Berry Group's 13F filing for Q4 2020, filed 11 Feb 2021.